HFE 282Y MUTATIONS ARE ASSOCIATED WITH SEVERITY OF LUNG DISEASE AND RATE OF LUNG FUNCTION DECLINE IN CYSTIC FIBROSIS

被引：0
|
作者：
Smith, D. [1 ,2 ,3 ]
Bell, S. [1 ,2 ]
Anderson, G. [2 ,3 ]
Reid, D. [1 ,2 ,3 ]
机构：
[1] Prince Charles Hosp, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld 4072, Australia
[3] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
来源：
RESPIROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [31] T Cell Hyporesponsiveness To Pseudomonas AerugINOSa In Cystic Fibrosis Relates To Rate Of Lung Function Decline
    Bailey, E. P.
    Cernadas, M.
    Duan, B.
    Priebe, G. P.
    Gerard, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [32] EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS
    Lee, Tim
    Sawicki, Gregory S.
    Altenburg, Josje
    Millar, Stefanie J.
    Geiger, Jessica Morlando
    Jennings, Mark T.
    Lou, Yiyue
    McGarry, Lisa J.
    Van Brunt, Kate
    Linnemann, Rachel W.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (03) : 402 - 406
  • [33] Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data
    Schluchter, Mark D.
    Konstan, Michael W.
    Drumm, Mitchell L.
    Yankaskas, James R.
    Knowles, Michael R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) : 780 - 786
  • [34] Lung Macrophage Function in Cystic Fibrosis - Regional Differences Correlating with Severity of Lung Damage
    Seidler, D.
    Nymon, A.
    Czum, J.
    Dorman, D.
    Dessaint, J.
    Ashare, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [35] Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
    Marsac, Charlotte
    Berdah, Laura
    Thouvenin, Guillaume
    Sermet-Gaudelus, Isabelle
    Corvol, Harriet
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [36] Laboratory biomarkers for lung disease severity and progression in cystic fibrosis
    Bene, Zsolt
    Fejes, Zsolt
    Macek, Milan, Jr.
    Amaral, Margarida D.
    Balogh, Istvan
    Nagy, Bela, Jr.
    CLINICA CHIMICA ACTA, 2020, 508 : 277 - 286
  • [37] AZTREONAM LYSINE INHALATION SOLUTION STABILISES LUNG FUNCTION DECLINE IN PATIENTS WITH CYSTIC FIBROSIS AND MODERATE TO SEVERE LUNG DISEASE
    Chadwick, H. K.
    White, H.
    Shaw, N.
    Etherington, C.
    Clifton, I
    Pollard, K.
    Whitaker, P.
    Peckham, D.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 331 - 331
  • [38] A semiparametric approach to estimate rapid lung function decline in cystic fibrosis
    Szczesniak, Rhonda D.
    McPhail, Gary L.
    Duan, Leo L.
    Macaluso, Maurizio
    Amin, Raouf S.
    Clancy, John P.
    ANNALS OF EPIDEMIOLOGY, 2013, 23 (12) : 771 - 777
  • [39] Lung function decline from adolescence to young adulthood in cystic fibrosis
    VandenBranden, Stacy L.
    McMullen, Ann
    Schechter, Michael S.
    Pasta, David J.
    Michaelis, Rory L.
    Konstan, Michael W.
    Wagener, Jeffrey S.
    Morgan, Wayne J.
    McColley, Susanna A.
    PEDIATRIC PULMONOLOGY, 2012, 47 (02) : 135 - 143
  • [40] THE CONTRIBUTION OF PULMONARY EXACERBATIONS TO LUNG FUNCTION DECLINE IN CYSTIC FIBROSIS PATIENTS
    Stanojevic, S.
    Ratjen, F.
    Atenafu, E.
    Lu, A.
    Yau, Y.
    Tullis, E.
    Waters, V
    PEDIATRIC PULMONOLOGY, 2011, : 333 - 334
12345